Unlike ER−/HER2+ tumors, which tend to be HER2-E by intrinsic subtyping, ER+/HER2+ breast cancers have a high proportion in the luminal A and luminal B categories, suggesting a different tumor biology8–10. This evidence concerns the gene ESR1 and breast carcinoma.